Search by Drug Name, NDC or Jcode
Internal Navigation
HCPCS Details
HCPC | J9022 |
Short Description | Inj, atezolizumab,10 mg |
Long Description | Injection, atezolizumab, 10 mg |
Pricing indicator | 51 |
Coverage code | C |
ASC payment group code | YY |
BETOS2 code | O1D |
Action code | N |
Type of service | 1 |
Effective date | 2018-01-01 |
Date Added | 2018-01-01 |
HCPCS/NDC Cross-Walk
NDC | HCPC | Description | Drug Name | Labeler Name | HCPCS Dosage | PKG Size | PKG QTY | Bill Units | Bill Units PKG |
---|---|---|---|---|---|---|---|---|---|
50242091701 | J9022 | Inj, atezolizumab,10 mg | TECENTRIQ (atezolizumab) | GENENTECH, INC. | 10 MG | 20 | 1 | 120 | 120 |
50242091801 | J9022 | Inj, atezolizumab,10 mg | Tecentriq | GENENTECH, INC. | 10 MG | 14 | 1 | 84 | 84 |
HCPCS Billing Calculator
Dosage given to patient (per dose) | |
---|---|
HCPCS Dosage | 10 MG |
HCPCS/CPT Billing Units | 0.1 |
Total doses ordered | |
Billing Units | 0.1 |
Drug Details
-
Atezolizumab injection is used alone or with other chemotherapy medications to treat certain types of non-small cell lung cancer (NSCLC) in adults. Atezolizumab injection is also used in combination with other chemotherapy medications to treat certain types of small cell lung cancer (SCLC), hepatocellular carcinoma (HCC), and melanoma (a type of skin cancer) in adults. Atezolizumab is also used alone to treat certain types of alveolar soft tissue sarcomas (cancer that forms in muscles, fat, or nerves) in adults and children 2 years of age or older. Atezolizumab injection is in a class of medications called monoclonal antibodies. It works by blocking the action of a certain protein in cancer cells. This helps the person's immune system to fight against the cancer cells, and helps to slow tumor growth.
-
Your doctor will review your specific type of cancer and past treatment history and other available treatments to determine if atezolizumab injection is right for you.